$STAB News February 15, 2022 Statera Biopharma, I
Post# of 6022
(Total Views: 117)
Posted On: 03/01/2022 7:26:13 AM
$STAB News February 15, 2022
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html
(0)
(0)Scroll down for more posts ▼